Scientists test stem cell infusions to slow Parkinson's
NCT ID NCT07232147
Summary
This early-stage study aims to test the safety and initial effects of stem cells from umbilical cords in people with Parkinson's disease. Twenty participants will receive either the stem cells or a placebo, given through an IV and sometimes also as a nasal spray. The main goal is to see if the treatment is safe and well-tolerated, while also checking for any early signs it might help with movement problems and other symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MOVEMENT DISORDERS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.